Vaccines are our passion. Our team of 1,100 employees brings together diverse sets of professionals from all the fields necessary for developing and providing vaccines to people across Europe. We’re proud to be a part of both the Merck and Sanofi global networks of leading biomedical expertise, while fostering the dedicated spirit of a smaller organisation focused on the needs of a single continent. For more information about how to join our team, visit our Sanofi Pasteur MSD Careers page.
Our Leadership Team
Jean-Paul Kress MD, President & Chief Executive Officer, Sanofi Pasteur MSD
Jean-Paul Kress is President & Chief Executive Officer of Sanofi Pasteur MSD. He leads the company’s corporate teams and 19-country affiliates in the development and delivery of more than twenty-five innovative vaccines specifically within the unique European context.
Prior to joining Sanofi Pasteur MSD, Jean-Paul was Vice President and General Manager in France for Gilead, a major US-based biopharmaceutical company specialised in therapeutics to treat life-threatening diseases such as HIV. He joined Gilead in 2006 as Vice President, US Sales and Marketing, Antiviral Business Unit. During his five years within the company, he ensured strong business results, growing the products and affiliates he managed by double digits, while also delivering new HIV treatments such as Gilead’s Single Tablet HIV Regimen. Jean-Paul launched his career in the pharmaceutical industry in 1993 as a product manager for Prozac at Eli Lilly and then held a number of sales, marketing and General Management positions in Europe and in the USA for Abbott Laboratories.
Jean-Paul Kress holds a MD Degree from Faculté Necker-Enfants Malades in Paris, France, and a Post-Graduate Degree in Pharmacology and Immunology from Ecole Normale Supérieure in Paris, France.
Didier Blondel, Vice President, Chief Financial Officer, Sanofi Pasteur MSD
Didier Blondel is Vice President Finance and Services, Sanofi Pasteur MSD, where he oversees Finance – accounting, controlling, tax and treasury – Information Systems – I.S. and I.T. – Purchasing, General Services and Real Estate activities at the European level. Prior to joining the company in January 2012, Didier acquired a vast amount of international experience within Sanofi over the last 20 years, mostly in CFO roles in Pharmaceutical Operations and R&D. During that period, he has been instrumental in deep transformation and change management initiatives. Didier graduated from ICN Business School (Nancy), and holds a Master Degree in Finance and Accounting (Nancy). He started his career in External Auditing for PriceWaterhouseCoopers.
Stephen Lockhart, Vice President, Development, Sanofi Pasteur MSD
Stephen Lockhart joined Sanofi Pasteur MSD as Vice President for Development in August 2013. He is responsible for the company’s Clinical Research, Epidemiology, Regulatory & Scientific Affairs, Pharmacovigilance & Risk Management, Quality & Pharmaceutical Affairs and Development Operational Excellence. From 2007 until 2013 Stephen was with Emergent BioSolutions, joining as President of Emergent Product Development UK and subsequently serving as Senior Vice President of Product Development and Vaccine Development. From 1995 until 2007 Stephen served with Wyeth Vaccines Research. In this role he was involved with the registration of Prevenar and Meningitec, as well as working on a wide range of other vaccines. Stephen studied medicine at the Universities of Cambridge and Oxford, graduating BM, BCh in 1980 and gained a DM from the Institute for Cancer Research. Stephen is a Fellow of the Faculty of Pharmaceutical Medicine.
Frederic Ganet, Vice President, Human Resources, Legal and Internal Communications, Sanofi Pasteur MSD
Frederic Ganet is Vice President Human Resources, Legal and Internal Communications Sanofi Pasteur MSD, where he leads development of the company’s HR strategies, and change & performance management. Prior to joining Sanofi Pasteur MSD in May 2011, Frederic was Senior Director, Global HR partner for R&D and CMO (Chief Medical Office) at Sanofi Pasteur, a company he first joined in 2005 as Director of Human Resources for Latin America and then Asia Pacific. Prior to joining Sanofi Pasteur, Frederic worked in HR management positions with Merial and Bayer CropScience. He holds a Master degree in Human Resources Management from Institut de Gestion Sociale de Lyon (IGS) and a Business, Psychology and Communications degree from the University of Aix en Provence.
Andrea Rappagliosi, Vice President, Market Access, Health Policy and Medical Affairs, Sanofi Pasteur MSD
Andrea Rappagliosi is the Vice President of Market Access, Health Policy and Medical Affairs at Sanofi Pasteur MSD.
Andrea most recently worked with GlaxoSmithKline as Vice President of European Government Affairs & Head of the Brussels Office. Since 1992, he has held pharmaceutical management positions at Serono International (now Merck Serono International), Baxter Healthcare, and The Ares-Serono Group. Throughout his career, he has been a member of key European pharmaceutical and bioscience boards, working groups and steering commitees. He was most recently named President of Vaccines Europe. Andrea began his career in the Italian Government. Andrea received a law degree from the University of Rome “La Sapienza” and obtained a Legislative Consultant Diploma (LLM) at the Istituto Superiore dei Studi Legislativi (ISLE) – Scuola di scienza e tecnica della legislazione.
Valérie Chevalier, Director, Chief of Staff & Shareholders Liaison, Sanofi Pasteur MSD
Valérie Chevalier is Director, Chief of Staff & Shareholders Liaison for Sanofi Pasteur MSD where she supports the President, providing strategic guidance and oversight on the company’s key initiatives. Prior to her current role, Valerie was Marketing Manager with the company for its European-wide efforts to deploy Influenza and Pneumo Vaccines. She was then appointed Director, Shareholders Liaison & Project Management, supporting the leadership team in its interactions on transversal issues and with the company’s shareholders. Before joining Sanofi Pasteur MSD in 2006, she held various local and international marketing positions for pharmaceutical leaders such as AstraZeneca and Merck Serono. She began her career in 1988 with Zeneca in France as a hospital representative. She holds a Ph.D. in Pharmacy from the Paris XI University and an MBA from the University of Hartford, Connecticut.
Etienne Rodriguez, Executive Director, Corporate Program Leadership, Sanofi Pasteur MSD
Etienne Rodriguez is Executive Director, Corporate Program Leadership, for Sanofi Pasteur MSD where he supports the Leadership Team in establishing the strategic programs roadmap and in providing transversal programs execution support and integration. Etienne joined Sanofi Pasteur MSD in 2007 as Director Controlling, Europe in a context of important growth. After significant achievements in this field, in 2012 he was appointed Program Senior Director for Finance transformation and in early 2013 for an initiative aiming at gearing up Compliance practices. Prior to joining the company, Etienne acquired a vast amount of international experience and change management in several Finance roles within Roche, Eaton and Bayer, in Commercial, Manufacturing and R&D operations. Etienne graduated from ESC Chambery Business School – with a specialization in Finance and Systems.
Marc-Olivier Lamaro, Chief Compliance Officer, Sanofi Pasteur MSD
Marc-Olivier Lamaro joined Sanofi Pasteur MSD as Chief Compliance Officer in February 2014. He leads the Compliance program across the Company’s Corporate teams and all country affiliates. Previously, he was Director of Compliance for Johnson & Johnson in France and then the United Kingdom. Marc-Olivier also has a diverse background, including work in Sales & Marketing with J&J, experience which he has applied throughout his ten-year compliance career in health care industries. He is a graduate of the Business and Management School in Paris. He also holds degrees from Seton Hall Law School in Newark, New Jersey (US) and an Anti-Corruption Certification from Sciences Po, Paris.
Oliver Sadlek, Vice President, General Manager, Germany and Austria, Sanofi Pasteur MSD
Oliver is Vice President, General Manager for Sanofi Pasteur MSD in Germany and Austria. He brings to this role 20 years of experience in the pharmaceutical industry. Prior to joining the company, he was Business Unit Director Diabetes for Sanofi Germany. He joined Sanofi Germany in 2010 after two years with Wyeth as Business Unit Director Bio-Pharma. In 1999, Oliver joined GlaxoSmithKline where he held different managerial and leadership positions including, from 2005 to 2008, Director Marketing and Sales HIV and Immunology. Olivier holds a PhD in Organic Chemistry obtained at the University of Munich.
Nicoletta Luppi, Vice President & General Manager, Sanofi Pasteur MSD, Italy
Nicoletta Luppi is Vice President and General Manager of Sanofi Pasteur MSD Italy, as well as Managing Director and President of the Board of Directors. Prior to joining Sanofi Pasteur MSD in September 2012, Nicoletta spent nearly twenty years with Merck Sharp & Dohme Italy (MSD), where she successfully managed various Business Units, the Cardiovascular Metabolic Franchise, two subsidiaries within the MSD Italy Group, the Primary Careof Schering Plough and, at last, Market Access & Commercial Operations. After earning an undergraduate degree in Modern Foreign Languages and Literature, she earned a Master’s Degree in Business Administration from the “L.U.I.S.S.” School of Management in Rome (Italy).
Richard Stubbins, Vice President & General Manager, Sanofi Pasteur MSD, UK
Richard Stubbins is Vice President and General Manager for Sanofi Pasteur MSD in the United Kingdom.
He joined Mérieux, the UK subsidiary of the pharmaceutical group Pasteur Mérieux Sérums et Vaccins in 1992, and, took his current position in 1995. Richard was instrumental in setting up a specialist trade body for the vaccine industry, the UK Vaccine Industry Group (UVIG). As UVIG Chairman, Richard has acted as the vaccine industry’s media spokesman and, in 2011, was invited to present on the UK industry at the inaugural European Influenza Summit. Richard was also a member of the joint Royal Society and Academy of Medical Sciences working group from 2008 to 2010 on Pandemic Influenza. He graduated from Liverpool University in Commerce, England and then qualified as a chartered accountant.
Serge Montero, Vice President & General Manager, Sanofi Pasteur MSD, France
Serge Montero is Vice President and General Manager for Sanofi Pasteur MSD in France. Prior to taking on this role in 2013, Serge was Vice President and General Manager of European Midsized Countries: Austria, Belgium, Denmark, Finland, Greece, Iceland, Ireland, Liechtenstein, Luxemburg, the Netherlands, Norway, Portugal, Sweden and Switzerland. He has served Sanofi Pasteur MSD and its family of companies for more than twenty years. Over that time he’s held leadership positions in Sales, Marketing, Business Management, Supply and Information Systems. He holds a Doctor in Science (PhD in Computer Sciences) degree from the Institut National des Sciences Appliquées, in Lyon, France, a Master in Finance and Banking from the Université de Lyon II and a Master in Applied Mathematics and a Master in Technological Sciences (Computer Sciences), both from the Université de Lyon I.
Ricardo Brage, Vice President & Managing Director, Sanofi Pasteur MSD, Spain
Ricardo Brage is Vice President and Managing Director for Sanofi Pasteur MSD in Spain. Prior to his current role, Ricardo was Business Unit Director Specialists and Hospitals, for MSD Spain. In all, Ricardo has more than twenty years of professional history with MSD/Merck & Co, where he held different positions of responsibility in the Sales and Marketing fields, as well as Operations and Business Development and Strategy, both at national and international levels. Prior to his two decades at Merck & Co/MSD, Ricardo began his professional career with Arthur Andersen. Ricardo has a degree in Economics from Denison University and an MBA from Houston University.
Marc Gailhardou, Vice President and General Manager, European Mid-Size Countries (EMC) Region
Marc is Vice President and General Manager, European Mid-Size Countries (EMC) Region: Belgium, Denmark, Finland, Greece, Iceland, Ireland, Luxemburg, the Netherlands, Norway, Portugal, Sweden and Switzerland. Marc joined from Sanofi Pasteur where he was Head of CEO’s Office. Prior to this role, Marc held franchise leadership positions and successfully contributed to the commercial development and strategic management of the Influenza and pediatric portfolio. Marc launched his career in the healthcare practice of Arthur Andersen and held successive marketing and sales roles within GlaxoSmithKline. Marc holds a Pharmaceutical Sciences Doctorate and an MBA from the London Business School (LBS).